25% Off SIBIONICS Discount Codes (6 Active) November 2024

About SIBIONICS

SIBIONICS, founded in 2015, is a pioneering healthcare technology company based in Shenzhen, China. Specializing in the research, development, and industrialization of high-end active implantable medical devices and medical artificial intelligence, SIBIONICS has made significant strides in transforming diabetes management. The company's primary focus is on continuous glucose monitoring (CGM) systems, which have been integrated into the inpatient treatment of over 1,600 hospitals and used by more than 600,000 people worldwide.

Standout Features of SIBIONICS CGM Systems

Continuous Glucose Monitoring

SIBIONICS' CGM systems, such as the GS1 CGM, offer 14-day continuous glucose monitoring without the need for finger pricking. This system provides real-time glucose data transmission to mobile devices and generates ambulatory glucose profile reports, enhancing patient care and management.

Integration with Healthcare Platforms

The GS1 CGM seamlessly integrates with the ProView remote access platform, allowing healthcare providers to monitor patients' glucose levels remotely. This integration facilitates better patient care and improves the efficiency of healthcare services.

AI-Driven Innovations

SIBIONICS has also developed AI-aided diagnostic tools, such as the eye-si AI fundus screening system, which uses deep-learning technology to detect fundus lesions. This innovation underscores the company's commitment to leveraging advanced technologies for better health outcomes.

User-Centered Design

SIBIONICS' products are designed with user convenience in mind. For instance, the company introduced the first blood-glucose meter without finger pricking in November 2021, making glucose monitoring more accessible and less invasive.

Frequently Asked Questions (FAQs)

When was SIBIONICS founded?

SIBIONICS was founded in 2015.

Where is SIBIONICS' headquarters?

SIBIONICS' headquarters is located at Suite 4A, Building 3, Tinwe Business Park, 6 Liufang Road, Shenzhen, China.

What is SIBIONICS' latest funding round?

SIBIONICS' latest funding round is Series D, where the company raised a total of $150.31 million.

What products does SIBIONICS offer?

SIBIONICS offers continuous glucose monitoring (CGM) systems, such as the GS1 CGM, and AI-aided diagnostic tools like the eye-si AI fundus screening system.

How does SIBIONICS' CGM system work?

SIBIONICS' CGM system provides 14-day continuous glucose monitoring, transmits glucose data to mobile devices, and generates ambulatory glucose profile reports. It also integrates with the ProView remote access platform for healthcare providers.

Is SIBIONICS' CGM system available globally?

SIBIONICS' CGM system has been integrated into hospitals worldwide and is gradually becoming available for pre-sales across European Union countries and the United Kingdom.